Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Interest Coverage Ratio (2016 - 2025)

Northwest Biotherapeutics (NWBO) has 16 years of Interest Coverage Ratio data on record, last reported at 5.46 in Q3 2025.

  • For Q3 2025, Interest Coverage Ratio rose 23.22% year-over-year to 5.46; the TTM value through Sep 2025 reached 7.6, up 21.49%, while the annual FY2024 figure was 8.56, 19.15% up from the prior year.
  • Interest Coverage Ratio reached 5.46 in Q3 2025 per NWBO's latest filing, up from 8.09 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 5.46 in Q3 2025 and bottomed at 15.37 in Q2 2021.
  • Average Interest Coverage Ratio over 5 years is 10.5, with a median of 10.39 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: soared 52.26% in 2022, then crashed 95.52% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 15.37 in 2021, then grew by 3.16% to 14.89 in 2022, then grew by 18.11% to 12.19 in 2023, then skyrocketed by 39.01% to 7.44 in 2024, then increased by 26.52% to 5.46 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 5.46 in Q3 2025, 8.09 in Q2 2025, and 10.81 in Q1 2025.